Tuberculosis and chronic kidney disease: an emerging global syndemic

Kidney International

Volumn 90, Issue 1, 2016, Pages 34-40

  Romanowski, Kamila ^a   Clark, Edward G ^b   Levin, Adeera ^a   Cook, Victoria J ^a   Johnston, James C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

chronic kidney disease; dialysis; global burden of disease; kidney transplant; tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

CHINA; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG EFFECT; END STAGE RENAL DISEASE; EPIDEMIC; EVIDENCE BASED MEDICINE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HUMAN; INDIA; INFECTION RISK; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; POVERTY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SCREENING TEST; SHORT SURVEY; TREATMENT PLANNING; TUBERCULOSIS; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL TRIAL (TOPIC); COMORBIDITY; COMPLICATION; ENDEMIC DISEASES; HEMODIALYSIS; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY TRANSPLANTATION; MASS SCREENING; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ANTITUBERCULAR AGENTS; CHINA; CLINICAL TRIALS AS TOPIC; COMORBIDITY; ENDEMIC DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSION; INDIA; KIDNEY TRANSPLANTATION; MASS SCREENING; NEPHRITIS, INTERSTITIAL; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TUBERCULOSIS;

EID: 84988433384     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.01.034     Document Type: Short Survey

References (44)

1. 1 Pradhan, R.P., Katz, L.A., Nidus, B.D., et al. Tuberculosis in dialyzed patients. JAMA 229 (1974), 798–800.
2. 2 Dobler, C.C., McDonald, S.P., Marks, G.B., Risk of tuberculosis in dialysis patients: a nationwide cohort study. PloS One, 6, 2011, e29563.
3. 3 Al-Efraij K, Mota L, Lunny C, et al. Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis. Int J Tuberc Lung Dis, in press.
4. 4 Vaziri, N.D., Pahl, M.V., Crum, A., et al. Effect of uremia on structure and function of immune system. J Ren Nutr 22 (2012), 149–156.
5. 5 Hussein, M.M., Mooij, J.M., Roujouleh, H., Tuberculosis and chronic renal disease. Semin Dial 16 (2003), 38–44.
6. 6 Richardson, R.M., The diagnosis of tuberculosis in dialysis patients. Semin Dial 25 (2012), 419–422.
7. 7 Rogerson, T.E., Chen, S., Kok, J., et al. Tests for latent tuberculosis in people with ESRD: a systematic review. Am J Kidney Dis 61 (2013), 33–43.
8. 8 Ferguson, T.W., Tangri, N., Macdonald, K., et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. Transplantation 99 (2015), 1084–1091.
9. 9 Jha, V., Garcia-Garcia, G., Iseki, K., et al. Chronic kidney disease: global dimension and perspectives. Lancet 382 (2013), 260–272.
10. 10 WHO. Global Tuberculosis Report 2014. (Suppl. CVS Data). 2014, World Health Organization, Geneva, Switzerland.
11. 11 Lozano, R., Naghavi, M., Foreman, K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2013), 2095–2128.
12. 12 Hossain, M.P., Goyder, E.C., Rigby, J.E., El Nahas, M., CKD and poverty: a growing global challenge. Am J Kidney Dis 53 (2009), 166–174.
13. 13 Liyanage, T., Ninomiya, T., Jha, V., et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385 (2015), 1975–1982.
14. 14 Collins, A.J., Foley, R.N., Gilbertson, D.T., et al. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int 5:Suppl. (2015), 2–7.
15. 15 Fresenius Medical Care. ESRD Patients in 2013: A Global Perspective. 2012, Fresenius Medical Care, Bad Homburg, Germany.
16. 16 Zuo, L., Wang, M., Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 74 (2010), S20–S22.
17. 17 Maquid, El, Nahas, A., Bello, A.K., Chronic kidney disease: the global challenge. Lancet 365 (2005), 331–340.
18. 18 WHO. Global Tuberculosis Report 2014. 2014, World Health Organization, Geneva, Switzerland.
19. 19 WHO. Towards Tuberculosis Elimination: An Action Framework for Low-Incidence Countries. 2015, World Health Organization, Geneva, Switzerland.
20. 20 Carrero, J.J., Stenvinkel, P., Inflammation in end-stage renal disease—what have we learned in 10 years?. Semin Dial 23 (2010), 498–509.
21. 21 Kato, S., Chmielewski, M., Honda, H., et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3 (2008), 1526–1533.
22. 22 Linquist, J.A., Rosaia, C.M., Riemer, B., et al. Tuberculosis exposure of patients and staff in an outpatient hemodialysis unit. Am J Infect Control 30 (2002), 307–310.
23. 23 Jereb, J.A., Burwen, D.R., Dooley, S.W., et al. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of mycobacterium tuberculosis isolates. J Infect Dis 168 (1993), 1219–1224.
24. 24 Singh, N., Paterson, D.L., Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 27 (1998), 1266–1277.
25. 25 Fried, L.F., Katz, R., Sarnak, M.J., et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16 (2005), 3728–3735.
26. 26 Lönnroth, K., Roglic, G., Harries, A.D., Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabet Endocrinol 2 (2014), 730–739.
27. 27 Segall, L., Covic, A., Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol 5 (2010), 1114–1122.
28. 28 Akpolat, T., Tuberculous peritonitis. Perit Dial Int 29:Suppl 2 (2009), S166–S169.
29. 29 British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn, H., Ashman, N., Davies, P., et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax 65 (2010), 559–570.
30. 30 Sester, M., van Leth, F., Bruchfeld, J., et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med 190 (2014), 1168–1176.
31. 31 Currie, A.C., Knight, S.R., Morris, P.J., Tuberculosis in renal transplant recipients: the evidence for prophylaxis. Transplantation 90 (2010), 695–704.
32. 32 Lichtenstein, I.H., MacGregor, R.R., Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 5 (1983), 216–226.
33. 33 Fischer, S., Avery, R.K., Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 9:suppl 4 (2009), S7–S18.
34. 34 Muñoz, P., Rodríguez, C., Bouza, E., Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 40 (2005), 581–587.
35. 35 Banu Rekha, V.V., Santha, T., Jawahar, M.S., Rifampicin-induced renal toxicity during retreatment of patients with pulmonary tuberculosis. J Assoc Physicians India 53 (2005), 811–813.
36. 36 WHO. Guidelines on the Management of Latent Tuberculosis Infection. 2015, World Health Organization, Geneva, Switzerland.
37. 37 American Thoracic Society. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. 2000, American Thoracic Society, Atlanta, Ga.
38. 38 Morris, M.I., Daly, J.S., Blumberg, E., et al. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant 12 (2012), 2288–2300.
39. 39 Dudley, C., Harden, P., Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient. Nephron Clin Pract 118:Suppl. 1 (2011), c209–c224.
40. 40 Peoples, M., Canadian Tuberculosis Standards. 2014, Public Health Agency of Canada, the Lung Association, and Canadian Thoracic Society, Ottawa, Ontario, Canada.
41. 41 Knoll, G., Cockfield, S., Blydt-Hansen, T., et al. Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ 173 (2005), S1–S25.
42. 42 European Centre for Disease Prevention and Control. Use of Interferon-Gamma Release Assays in Support of TB Diagnosis. 2011, European Centre for Disease Prevention and Control, Stockholm, Sweden.
43. 43 NICE. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. 2011, National Collaborating Centre for Chronic Conditions and Centre for Clinical Practice at NICE, London, UK.
44. 44 Levey, A.S., Eckardt, K.-U., Tsukamoto, Y., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005), 2089–2398.